ADVERTISEMENT

Peter Sonnenreich, Contributing Writer

Emma Guttman-Yassky, MD, PhD

Feature Story

Positive Results Revealed for Atopic Dermatitis Investigational Drug Etrasimod

10/10/2021

Peter Sonnenreich ;

Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.

Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.

Recently presented clinical...

10/10/2021

The Dermatologist

Vitiligo of the hands

Feature Story

Topical JAK Inhibitor Offers Promise for Two Skin Diseases

09/15/2021

Peter Sonnenreich ;

Mary Anne Dunkin ;

A number of emerging therapies involving the JAK-STAT pathway are in the pipeline for immune-mediated inflammatory diseases. One particular Janus kinase inhibitor shows potential for atopic dermatitis and vitiligo.

A number of emerging therapies involving the JAK-STAT pathway are in the pipeline for immune-mediated inflammatory diseases. One particular Janus kinase inhibitor shows potential for atopic dermatitis and vitiligo.

A number of emerging therapies...

09/15/2021

The Dermatologist

Tralokinumab: A New Potential for Atopic Dermatitis

Partner Approved

Tralokinumab: A New Potential for Atopic Dermatitis

09/11/2020

Peter Sonnenreich ;

New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.

New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.

New biologic therapy...

09/11/2020

The Dermatologist

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement